Long COVID, also known as post-COVID-19 syndrome, is a condition in which symptoms of COVID-19 persist for weeks or even months after the acute infection has subsided. This condition can cause a wide range of symptoms, ranging from fatigue and shortness of breath to neurological and cognitive issues. In this blog, we explore the role of nicotinamide mononucleotide (NMN) in potentially treating Long COVID, supported by recent research.
What is Long COVID?
Long COVID is a complex condition that affects the lives of millions of people worldwide. Symptoms may include:
- Extreme fatigue
- Shortness of breath
- Persistent cough
- Muscle and joint pain
- Cognitive disorders such as ‘brain fog’
- Heart palpitations
The exact causes of Long COVID are still under investigation, but possible mechanisms include persistent inflammation, autoimmune reactions, and viral persistence.
NMN: What is it?
Nicotinamide mononucleotide (NMN) is a molecule that plays an important role in the production of nicotinamide adenine dinucleotide (NAD+), a co-enzyme that is essential for cellular energy production and DNA repair. NAD+ levels decrease with age and in various diseases, contributing to fatigue and reduced health.
NMN and lung COVID: A promising treatment
The pandemic has led to an urgent need for effective treatments for Long COVID, a condition that affects patients long after the acute infection has cleared. NMN is emerging as a promising option due to its role in increasing NAD+ levels in the body. NAD+ is crucial for cell repair and energy production, and supplementation with NMN can help replenish depleted NAD+ levels in Long COVID patients.
Research shows that NMN can not only help restore energy levels but also improve mitochondrial function, which is essential for reducing fatigue and muscle weakness commonly experienced in Long COVID. In addition, NMN may help reduce oxidative stress and inflammation, factors associated with long-term COVID symptoms. These combined effects make NMN a potential key player in addressing the long-term effects of COVID-19, offering hope to patients worldwide.
NMN and Long COVID: The investigation.
Recent studies suggest that NMN may play a potential therapeutic role in the treatment of Long COVID. Here are some key findings:
- Energy Levels and Fatigue: Research shows that NMN can increase NAD+ levels, which can help improve energy production in cells. This may be particularly useful for Long COVID patients suffering from severe fatigue.
- Anti-Inflammatory Properties: NMN also has anti-inflammatory properties. A study published in Nature Metabolism showed that NMN can reduce inflammatory responses, which may be helpful in managing persistent inflammation in Long COVID.
- Cognitive Improvements: Long COVID patients often report cognitive issues such as ‘brain fog.’ Studies with NMN have shown improvements in cognitive functions, suggesting that it may help reduce neurological symptoms of Long COVID.
How to use NMN.
NMN is available in supplement form and can be taken orally. However, it is important to consult a doctor before starting to take NMN, especially if you have underlying health issues or are taking other medications.
Conclusion
The treatment of Long COVID remains a challenge due to the diversity and persistence of symptoms. NMN offers a promising therapeutic perspective, with the potential to improve energy production, reduce inflammation, and support cognitive functions. While more research is needed to fully understand the effects of NMN on Long COVID, current findings may offer hope to those struggling with this debilitating condition.
Resources
- Energy Levels and Fatigue
- Anti-inflammatory Properties
- Cognitive Enhancements
Due to the ongoing developments in scientific research, it remains important to stay informed about new findings and treatment methods. Always consult a medical professional for personalized advice and treatment.
View our NMN products
